Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 7,213-7,224 of 10,592

Drug study icon

CompletedNCT01172275

N-acetylcysteine (NAC) for Pediatric OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 8 Years to 17 Years

Countries: United States
Sponsor: Yale University
Condition: OCD

Behavioral study icon

CompletedNCT00751257

N-Acetylcysteine and Smoking Reduction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Drug study icon

TerminatedNCT02335060

N-acetylcysteine Effects on Tetrahydrocannabinol

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Behavioral study icon

CompletedNCT02737358

N-acetylcysteine for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Behavioral study icon

CompletedNCT03707951

N-Acetylcysteine for Adolescent Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 13 Years to 25 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Behavioral study icon

CompletedNCT04627922

N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Ellen Herbst
Condition: Addiction

Behavioral study icon

CompletedNCT03055377

N-Acetylcysteine for Youth Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 14 Years to 21 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Drug study icon

TerminatedNCT01131572

N-acetylcysteine in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Eating disorders

Drug study icon

TerminatedNCT01033149

N-acetylcysteine in the Treatment of Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Eating disorders

Behavioral study icon

CompletedNCT02791945

N-acetylcysteine Treatment of Addiction In Veterans With TBI

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: Addiction

Drug study icon

WithdrawnNCT05710887

N2O for Acute Suicide prevention and Depression in the ED

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States

Depression, SuicidalityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Chicago
Condition: Depression, Suicidality

Drug study icon

TerminatedNCT03251326

Nabilone in Cannabis Users With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.